These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 14526315)

  • 1. The role of activity-dependent neuroprotective protein in a mouse model of fetal alcohol syndrome.
    Poggi SH; Goodwin K; Hill JM; Brenneman DE; Tendi E; Schinelli S; Abebe D; Spong CY
    Am J Obstet Gynecol; 2003 Sep; 189(3):790-3. PubMed ID: 14526315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of c-fos in a mouse model of fetal alcohol syndrome.
    Poggi SH; Goodwin KM; Hill JM; Brenneman DE; Tendi E; Schninelli S; Spong CY
    Am J Obstet Gynecol; 2003 Sep; 189(3):786-9. PubMed ID: 14526314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of embryonic and maternal activity-dependent neuroprotective protein during mouse development.
    Poggi SH; Vink J; Goodwin K; Hill JM; Brenneman DE; Pinhasov A; Gozes I; Spong CY
    Am J Obstet Gynecol; 2002 Oct; 187(4):973-6. PubMed ID: 12388989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of the alcohol-induced changes in brain-derived neurotrophic factor expression using neuroprotective peptides in a model of fetal alcohol syndrome.
    Incerti M; Vink J; Roberson R; Benassou I; Abebe D; Spong CY
    Am J Obstet Gynecol; 2010 May; 202(5):457.e1-4. PubMed ID: 20452488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective peptides prevent some alcohol-induced alteration in gamma-aminobutyric acid A-beta3, which plays a role in cleft lip and palate and learning in fetal alcohol syndrome.
    Toso L; Roberson R; Abebe D; Spong CY
    Am J Obstet Gynecol; 2007 Mar; 196(3):259.e1-5. PubMed ID: 17346546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective peptides influence cytokine and chemokine alterations in a model of fetal alcohol syndrome.
    Roberson R; Kuddo T; Benassou I; Abebe D; Spong CY
    Am J Obstet Gynecol; 2012 Dec; 207(6):499.e1-5. PubMed ID: 23174390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with neuropeptides attenuates c-fos expression in a mouse model of fetal alcohol syndrome.
    Incerti M; Vink J; Roberson R; Abebe D; Spong CY
    Am J Perinatol; 2010 Oct; 27(9):743-8. PubMed ID: 20446212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity-dependent neuroprotective protein: from gene to drug candidate.
    Gozes I
    Pharmacol Ther; 2007 May; 114(2):146-54. PubMed ID: 17363064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity-dependent neuroprotective protein snippet NAP reduces tau hyperphosphorylation and enhances learning in a novel transgenic mouse model.
    Vulih-Shultzman I; Pinhasov A; Mandel S; Grigoriadis N; Touloumi O; Pittel Z; Gozes I
    J Pharmacol Exp Ther; 2007 Nov; 323(2):438-49. PubMed ID: 17720885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection against tauopathy by the drug candidates NAP (davunetide) and D-SAL: biochemical, cellular and behavioral aspects.
    Shiryaev N; Pikman R; Giladi E; Gozes I
    Curr Pharm Des; 2011; 17(25):2603-12. PubMed ID: 21728979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective fractalkine in fetal alcohol syndrome.
    Roberson R; Kuddo T; Benassou I; Abebe D; Spong C
    Am J Obstet Gynecol; 2011 May; 204(5):400.e1-3. PubMed ID: 21572545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity-dependent neuroprotective protein: a novel gene essential for brain formation.
    Pinhasov A; Mandel S; Torchinsky A; Giladi E; Pittel Z; Goldsweig AM; Servoss SJ; Brenneman DE; Gozes I
    Brain Res Dev Brain Res; 2003 Aug; 144(1):83-90. PubMed ID: 12888219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of alcohol-induced learning deficits in the young adult in a model of fetal alcohol syndrome.
    Incerti M; Vink J; Roberson R; Wood L; Abebe D; Spong CY
    Obstet Gynecol; 2010 Feb; 115(2 Pt 1):350-356. PubMed ID: 20093910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression of activity-dependent neuroprotective protein (ADNP) is regulated by brain damage and treatment of mice with the ADNP derived peptide, NAP, reduces the severity of traumatic head injury.
    Gozes I; Zaltzman R; Hauser J; Brenneman DE; Shohami E; Hill JM
    Curr Alzheimer Res; 2005 Apr; 2(2):149-53. PubMed ID: 15974912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity-dependent neuroprotective protein (ADNP) is an alcohol-responsive gene and negative regulator of alcohol consumption in female mice.
    Ziv Y; Rahamim N; Lezmy N; Even-Chen O; Shaham O; Malishkevich A; Giladi E; Elkon R; Gozes I; Barak S
    Neuropsychopharmacology; 2019 Jan; 44(2):415-424. PubMed ID: 30008470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptidergic agonists of activity-dependent neurotrophic factor protect against prenatal alcohol-induced neural tube defects and serotonin neuron loss.
    Zhou FC; Fang Y; Goodlett C
    Alcohol Clin Exp Res; 2008 Aug; 32(8):1361-71. PubMed ID: 18565153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain deficits associated with fetal alcohol exposure may be protected, in part, by peptides derived from activity-dependent neurotrophic factor and activity-dependent neuroprotective protein.
    Sari Y; Gozes I
    Brain Res Rev; 2006 Aug; 52(1):107-18. PubMed ID: 16488478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The autism/neuroprotection-linked ADNP/NAP regulate the excitatory glutamatergic synapse.
    Sragovich S; Malishkevich A; Piontkewitz Y; Giladi E; Touloumi O; Lagoudaki R; Grigoriadis N; Gozes I
    Transl Psychiatry; 2019 Jan; 9(1):2. PubMed ID: 30664622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of NADPH oxidase in a mouse model of fetal alcohol syndrome.
    Hill AJ; Drever N; Yin H; Tamayo E; Saade G; Bytautiene E
    Am J Obstet Gynecol; 2014 May; 210(5):466.e1-5. PubMed ID: 24334207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of learning deficit in a Down syndrome model.
    Incerti M; Toso L; Vink J; Roberson R; Nold C; Abebe D; Spong CY
    Obstet Gynecol; 2011 Feb; 117(2 Pt 1):354-361. PubMed ID: 21252750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.